IsoPlexis Blog Efficiency with Excellence: Expedite Cell Line Development Timelines with the Beacon Platform's Selective Cell Cloning

In the biopharmaceutical industry, where lengthy antibody therapeutic development timelines can delay critical treatments for patients in need, accelerating cell line development (CLD) has never been more crucial. The Beacon® optofluidic system by Bruker Cellular Analysis has emerged as a revolutionary platform, offering unparalleled efficiency in CLD processes by enabling a suite of powerful assays ...Efficiency with Excellence: Expedite Cell Line Development Timelines with the Beacon® Platform's Selective Cell Cloning Read More »The post Efficiency with Excellence: Expedite Cell Line Development Timelines with the Beacon® Platform's Selective Cell Cloning appeared first on Bruker Cellular Analysis.